BioSpace News Archive

Press Releases

Syndax Announces Participation in November 2026 Investor Conferences

October 30, 2026
·
1 min read
Press Releases

Alterity Therapeutics Releases Appendix 4C – Q1 FY27 Quarterly Cash Flow Report & Corporate Update

October 30, 2026
·
10 min read
Press Releases

Acumen Pharmaceuticals Announces Topline Results from Phase 2 ALTITUDE-AD Clinical Trial of Sabirnetug (ACU193) for the Treatment of Early Alzheimer’s Disease; Trial Did Not Meet Primary Endpoint

October 30, 2026
·
6 min read
Press Releases

NRx Pharmaceuticals (Nasdaq:NRXP) Receives FDA Approval of Preservative-Free Ketamine Ahead of November 10 FDA Goal Date

October 30, 2026
·
7 min read
Press Releases

Fractyl Health Strengthens Revita Patent Portfolio as It Advances Toward FDA Submission and Potential Commercialization

October 30, 2026
·
8 min read
Press Releases

Agios Announces New PDUFA Goal Date of February 1, 2027, for Mitapivat Sickle Cell Disease sNDA; Company Is Launch-Ready and in Labeling Discussions with FDA

October 30, 2026
·
15 min read
Press Releases

ILUMYA® (tildrakizumab-asmn) approved in the U.S. for the Treatment of Adults with Active Psoriatic Arthritis

October 30, 2026
·
8 min read
Press Releases

Latus Bio Announces New Preclinical Data Featuring High-Performing Engineered AAV Capsid Variants for Kidney and CNS Diseases at ESGCT 33rd Annual Congress

October 30, 2026
·
4 min read
Press Releases

Enhertu® Wins 2026 International Prix Galien Award for Best Biotechnology Product

October 30, 2026
·
20 min read
Press Releases

AstraZeneca results: 9M and Q3 2026

October 30, 2026
·
10 min read